Millions of Americans who need aggressive cholesterol lowering but dread regular injections now have a new option: a ...

The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...

Lipfendra (enlicitide) offers a convenient option for adults who haven’t been able to lower their cholesterol sufficiently with statins. The U.S. Food and Drug Administration (FDA) approved Lipfendra ...

A new treatment has been approved in the United States for people with high cholesterol.

For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as "bad cholesterol") low enough ...

A new daily pill will give people with stubbornly high cholesterol a cheaper, needle-free way to lower their levels.

Add Yahoo as a preferred source to see more of our stories on Google. Big news for those concerned about their heart health: Pharmaceutical company Merck has created a new pill called enlicitide, ...

Patients unable to control their cholesterol levels with medications may someday be able to lower their "bad" cholesterol with a shot, according to research presented at the American Heart Association ...

A one-off injection might be able to permanently reduce the risk of heart disease by reversibly switching off a gene in the liver, according to a study in mice. The findings suggest that the approach ...